• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

COMPARING CREAMS

Article

Investigators with Dermatology Associates, St. Luke's-Roosevelt Hospital, N.Y., conducted two 8-week, multi-center, randomized, investigator-blind studies to compare the efficacy and safety of a hydrophilic cream formulation containing tretinoin 0.05 percent, hydroquinne 4.0 percent and fluocinolone acetonide 0.01 percent (RA+HQ+FA) with the dual-combination agents tretinoin hydroquinone, tretinoin plus fluocinolone acetonide, and hydroquinone plus fluocinolone acetonide.

Recent Videos
Andrew Alexis, MD, MPH, an expert on vitiligo
Andrew Alexis, MD, MPH, an expert on vitiligo
Andrew Alexis, MD, MPH, an expert on vitiligo
Elizabeth Kiracofe, MD, FAAD, and Jenny Murase, MD, experts on atopic dermatitis
Elizabeth Kiracofe, MD, FAAD, and Jenny Murase, MD, experts on atopic dermatitis
This series features 1 KOL.
This series features 1 KOL.
© 2024 MJH Life Sciences

All rights reserved.